Lipid-lowering drugs and inflammatory bowel disease ’s risk: a drug-target Mendelian randomization study

Inflammatory bowel disease (IBD) has been associated with lipid-lowering drugs in observational studies. Drug-target Mendelian randomization (MR) was utilized in this study to examine the causal relationship b...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Tags: Research article Source Type: research